Found 47 matching trials
Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer
PHASE2This research study will investigate the safety and effectiveness of two di...
Location
University of Southern Alabama Mitchell Cancer Institute
Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy
PHASE2The overall aim of this project is to establish potential benefits of a nov...
Location
University Hospital Regensburg
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
PHASE4The DART-HA study is a single-center, open label, trial intended to evaluat...
Location
Heart Center Research, LLC
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
PHASE2This phase II trial studies how well therapeutic angiotensin-(1-7) works as...
Location
Wake Forest University Health Sciences
Angiotensin 1-7 as a Therapy in the Treatment of COVID-19
PHASE2Phase 2 ,double blind, randomized study of therapy with Angiotensin 1-7 in ...
Location
Rambam Medical Center
COVID-19: Collecting Measurements of Renin-angiotensin-system Markers, Such as Angiotensin-2 and Angiotensin 1-7
NAInvestigators study meet the World Health Organization definition of a clin...
Location
Cliniques Universitaires de Kinshasa
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
PHASE3REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Location
University of Florida
A Study of Blood Pressure Control During Cancer Treatment
PHASE2The purpose of this study to find out whether an intensive approach to trea...
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients
PHASE2Heart failure (HF) is the major cardiovascular disease that continues to gr...
Location
University of Arizona Sarver Heart Center
Angiotensin-(1,7) Treatment in COVID-19: the ATCO Trial
PHASE2Background: A novel Coronavirus (SARS-CoV-2) described in late 2019 in Wuha...
Location
Multiple Locations